Literature DB >> 15057494

Prostate operations: long-term effects on sexual and urinary function and quality of life. Comparison with an age-matched control population.

C Deliveliotis1, C Liakouras, A Delis, A Skolarikos, J Varkarakis, V Protogerou.   

Abstract

The purpose of this study was to investigate the effects of radical prostatectomy (RP) for prostate cancer, transurethral resection of the prostate (TURP) for benign prostate hyperplasia (BPH), and the alterations induced by ageing on quality of life, urinary and sexual function, and bother. We evaluated 283 patients who filled in and returned the questionnaire used. A total of 105 were treated with RP and were selected prostate cancer patients with localised disease without recurrences. An additional 98 underwent TURP for BPH and a third group consisted of 80 apparently healthy men. The general quality of life was estimated by the Rand 36-Item Health Survey 1.0. Urinary function was estimated by the AUA Symptom Index and the UCLA Prostate Cancer Index (urinary function and bother scale). Sexual function and bother, were explored using the Brief Male Sexual Function Inventory for Urology. Patient outcome 2 years post treatment was compared to the pre-treatment status and to that of the matched control population. General quality of life was not affected by RP or TURP, with the exception of an increase in the emotional/well being domain in RP patients to control group levels. After RP there was more bother reported for the urinary function than urinary malfunction itself, while TURP, as expected, restored urinary function and bother to normal population norms. Elderly males had urinary function and bother similar to the operated patients. Estimating sexual function on RP patients, erectile dysfunction (ED) predominates, leading to decreased sexual life. TURP marginally affects sexual life, mainly due to the loss of ejaculation, while in men from the control group, sexual function, although affected, was still present. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15057494     DOI: 10.1007/s00240-004-0411-0

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  16 in total

Review 1.  BPH and sexuality.

Authors:  A R Zlotta; C C Schulman
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

2.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

3.  Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.

Authors:  Y Arai; Y Aoki; K Okubo; H Maeda; N Terada; Y Matsuta; S Maekawa; K Ogura
Journal:  J Urol       Date:  2000-10       Impact factor: 7.450

4.  Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy.

Authors:  T C Kao; D F Cruess; D Garner; J Foley; T Seay; P Friedrichs; J B Thrasher; R D Mooneyhan; D G McLeod; J W Moul
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

5.  A brief male sexual function inventory for urology.

Authors:  M P O'Leary; F J Fowler; W R Lenderking; B Barber; P P Sagnier; H A Guess; M J Barry
Journal:  Urology       Date:  1995-11       Impact factor: 2.649

6.  The RAND 36-Item Health Survey 1.0.

Authors:  R D Hays; C D Sherbourne; R M Mazel
Journal:  Health Econ       Date:  1993-10       Impact factor: 3.046

7.  Quality of life in prostate cancer patients.

Authors:  S R Rossetti; C Terrone
Journal:  Eur Urol       Date:  1996       Impact factor: 20.096

Review 8.  Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment.

Authors:  Allen D Seftel
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

9.  The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

Authors:  M S Litwin; R D Hays; A Fink; P A Ganz; B Leake; R H Brook
Journal:  Med Care       Date:  1998-07       Impact factor: 2.983

10.  Recovery of health related quality of life in the year after radical prostatectomy: early experience.

Authors:  M S Litwin; K A McGuigan; A I Shpall; N Dhanani
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  10 in total

1.  Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.

Authors:  Samuel R Denmeade; Blair Egerdie; Gary Steinhoff; Rosemina Merchant; Ralph Abi-Habib; Peter Pommerville
Journal:  Eur Urol       Date:  2010-11-24       Impact factor: 20.096

2.  Prospective, randomized, double-blind, vehicle controlled, multicenter phase IIb clinical trial of the pore forming protein PRX302 for targeted treatment of symptomatic benign prostatic hyperplasia.

Authors:  Mostafa M Elhilali; Peter Pommerville; Richard C Yocum; Rosemina Merchant; Claus G Roehrborn; Samuel R Denmeade
Journal:  J Urol       Date:  2012-11-07       Impact factor: 7.450

Review 3.  Pharmacological Treatment of Post-Prostatectomy Incontinence: What is the Evidence?

Authors:  Anja Løvvik; Stig Müller; Hitendra R H Patel
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

4.  Erectile function recovery rate after radical prostatectomy: a meta-analysis.

Authors:  Raanan Tal; Hannah H Alphs; Paul Krebs; Christian J Nelson; John P Mulhall
Journal:  J Sex Med       Date:  2009-06-09       Impact factor: 3.802

5.  The influence of developmental life stage on quality of life in survivors of prostate cancer and their partners.

Authors:  Janet Harden; Laurel Northouse; Bernadine Cimprich; Joanne M Pohl; Jersey Liang; Trace Kershaw
Journal:  J Cancer Surviv       Date:  2008-03-14       Impact factor: 4.442

6.  Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia.

Authors:  Negin Hadi; Alireza Aminsharifi; Ali Sadeghi; Ali Tourchi
Journal:  Qual Life Res       Date:  2012-09-05       Impact factor: 4.147

7.  Hypogonadism in male cancer patients.

Authors:  Basil O Burney; Jose M Garcia
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-04-20       Impact factor: 12.910

8.  The Long-Term Effect of Radical Prostatectomy on Erectile Function, Urinary Continence, and Lower Urinary Tract Symptoms: A Comparison to Age-Matched Healthy Controls.

Authors:  Badereddin Mohamad Al-Ali; Anton Ponholzer; Herbert Augustin; Stephan Madersbacher; Karl Pummer
Journal:  Biomed Res Int       Date:  2017-02-05       Impact factor: 3.411

9.  Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).

Authors:  Annika Waldmann; Volker Rohde; Karen Bremner; Murray Krahn; Thomas Kuechler; Alexander Katalinic
Journal:  BMC Cancer       Date:  2009-08-23       Impact factor: 4.430

10.  HoLEP does not affect the overall sexual function of BPH patients: a prospective study.

Authors:  Sung Han Kim; Hyung-Kook Yang; Hahn-Ey Lee; Jae-Seung Paick; Seung-June Oh
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.